Encouraged by the relative strength of the dollar and improving financing conditions, US bidders are snapping up European assets -
Transatlantic M&A was enjoying record-high activity before the war in Ukraine sparked...more
9/15/2023
/ Acquisitions ,
Biotechnology ,
Capital Markets ,
EU ,
Financial Markets ,
Global Market ,
Investors ,
Mergers ,
Pharmaceutical Industry ,
Popular ,
Private Equity ,
Software ,
Technology Sector ,
UK
After a year of historic profits in 2021 following the mass roll-out of COVID-19 vaccines and related treatments, big pharma companies armed with cash for deals have been shifting their attention -
Overall, pharma, medical...more
2/3/2023
/ Acquisitions ,
Biotechnology ,
Coronavirus/COVID-19 ,
Global Dealmaking ,
Healthcare ,
Investment ,
Investors ,
Life Sciences ,
Mergers ,
Pharmaceutical Industry ,
Prescription Drugs ,
Vaccinations
Dealmaking activity in the US healthcare sector was robust in H1 2022 in the face of various macroeconomic headwinds. There were US$92.4 billion worth of deals announced in H1 2022. This was a 51 percent decrease from a...more